Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium
✍ Scribed by Irina Alafuzoff; Dietmar R. Thal; Thomas Arzberger; Nenad Bogdanovic; Safa Al-Sarraj; Istvan Bodi; Susan Boluda; Orso Bugiani; Charles Duyckaerts; Ellen Gelpi; Stephen Gentleman; Giorgio Giaccone; Manuel Graeber; Tibor Hortobagyi; Romana Höftberger; Paul Ince; James W. Ironside; Nikolaos Kavantzas; Andrew King; Penelope Korkolopoulou; Gábor G. Kovács; David Meyronet; Camelia Monoranu; Tatjana Nilsson; Piero Parchi; Efstratios Patsouris; Maria Pikkarainen; Tamas Revesz; Annemieke Rozemuller; Danielle Seilhean; Walter Schulz-Schaeffer; Nathalie Streichenberger; Stephen B. Wharton; Hans Kretzschmar
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 844 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0001-6322
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Aims To ensure that all Alzheimer centres across Europe are capable of using a similar method of data collection. Information about the patient assessment tools used by each participating centre was obtained and normal clinical practice in each EADC centre was documented by collecting data from
The aim of this study was to compare brain glial fibrillary acidic protein (GFAP) levels to the moditications of cognitive functions (Blessed test score [BTS]), the density of the main neuropathological lesions (senile plaques [SP] and neurofibrillary tangles [NFT]), and the density of the two main